Status:
COMPLETED
Detection and Quantification of Neonatal Intraventricular Hemorrhage
Lead Sponsor:
Electrical Geodesics, Inc.
Collaborating Sponsors:
University of Florida
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Intraventricular Brain Hemorrhage
Eligibility:
All Genders
30-34 years
Brief Summary
Dense array EEG and EIT (electrical impedence tomography) are new technologies that can add to information needed to diagnose neurological problems in infants - both preterm and term. The investigator...
Detailed Description
We propose to start with infants 32-34 weeks of gestation. Within this group, we will test the electrodes for increasing lengths of time. The first group will have the electrodes in place for 10 minut...
Eligibility Criteria
Inclusion
- Preterm infants 30-34 weeks gestation.
Exclusion
- Any infants with evidence of pre-existing skin condition, breakdown, rashes, or problems with skin integrity. Infants with a known neurological condition (hydrocephalus, Dandy Walker malformation, craniosynostosis, arteriovenous malformation) will be excluded as well. Also, secondary to the nature of the device and the surface area it takes up, infants on continuous positive airway pressure will be excluded as well.
Key Trial Info
Start Date :
May 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01899651
Start Date
May 1 2014
End Date
August 1 2016
Last Update
January 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UF Health Shands Hospital NICU
Gainsville, Florida, United States, 32608